Correlation between Genotype and Phenotype in Patients with Cystic Fibrosis

New England Journal of Medicine

Volumn 329, Issue 18, 1993, Pages 1308-1313

  Hamosh, Aba ^a   Rosenstein, B J ^a   Nash, E ^a   Curristin, S M ^a   Cutting, G R ^a   Macek, M ^a,b,b   McIntosh, I ^a,c   Krasnicanova H ^b   Vavrova V ^b   Zemkova D ^b   Keston, M ^c   Brock, D J H ^c   Corey, Mary ^d   Durie, P ^d   Levison, H ^d   Tsui, L C ^d   Aubin, G ^e   Simard, F ^e   Allard, C ^e   Morgan, K ^f   Fujiwara, M ^f   Daigneault, J ^g   de Braekeleer, M ^g   Grade, K ^h   Coutelle, C ^h   Graupner, I ⁱ   Leucht, B ^j   Harms, K ^k   Bertele, R ^k   Rosenecker, J ^k   Deufel, T ^k   Meitinger, T ^k   Wolf, A ^l   Kulozik, A ^l   Lindner, M ^l   Wulbrand, U ^m   Dork T ^m   Tummler B ^m   Stuhrmann, M ^m   Schmidtke, J ^m   Reis, A ⁿ   Burger J ⁿ   Bonduelle, M ^o   Lissens, W ^o   Efremov, G D ^p   Spona, J ^q   Kalaydjieva, L ^r   Angelicheva, D ^r   Cashman, S ^s   de Arce, M ^s   Hayes, J P ^t   Giunta, A M ^u   Assaisso, M L ^u   Sereni, L P ^v   Seia, M ^v   Ferrari, M ^w   Cremonesi, L ^w   Restagno, G ^x   Carbonara, A ^x   Garnerone, S ^x   Novelli, G ^y   Dallapiccola, B ^y   Borgo, G ^z   Mastella, G ^z   Kadasi, L ^aa   Ferak V ^aa   Gecz, J ^aa   Krivusova T ^aa   Kayserova H ^ab   Claustres, M ^ac   Super, M ^ad   Schwarz, M ^ad   Osborne, L ^ae   Santis, G ^ae   George, P M ^af   Wesley, A ^ag   Gilbert, F ^ah   Highsmith, W E ^ai   Fernald, G ^ai   Merten, D ^ai   Friedman, K J ^ai   Wood, B M ^ai   Silverman, L M ^ai   Knowles, M ^ai   Accurso, F J ^aj   Seltzer, W ^aj   Farmer, G ^ak   Shay, G F ^ak   Raskin, S ^al,ap   Louie, E ^am   Johnson, J P ^am   Cassiman, J J ^an   de Boeck, K ^an   Santini, B ^ao   Phillips, J A ^au   Gasparini, P ^aq   Pignatti, P F ^aq   Hardy, K ^ar   Palmer, J ^as   Kufardjieva, A ^at   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e CHICOUTIMI HOSPITAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^h MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

ⁱ Municipal Hospital   (Germany)

^j Department of Neuropediatrics   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l UNIVERSITY OF ULM   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

ⁿ FREIE UNIVERSITÄT BERLIN   (Germany)

^o FREE UNIVERSITY OF BRUSSELS   (Belgium)

^p MACEDONIAN ACADEMY OF SCIENCES AND ARTS   (Macedonia)

^q UNIVERSITY OF VIENNA   (Austria)

^r UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^s Psychotherapy and Community Health   (Ireland)

^t ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^u Regional Cystic Fibrosis Centre   (Italy)

^v PARKINSON INSTITUTE   (Italy)

^w SAN RAFFAELE HOSPITAL   (Italy)

^x CNR   (Italy)

^y UNIVERSITY OF ROME TOR VERGATA   (Italy)

^z Ospedale Civile Maggiore   (Italy)

^aa INSTITUTE OF CHEMISTRY   (Slovakia)

^ab Derer 's University Hospital Slovakia   (Slovakia)

^ac Institut De Biologie   (France)

^ad ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^ae ROYAL BROMPTON HOSPITAL   (United Kingdom)

^af Royal Brompton National Heart and Lung Institute ^*  (New Zealand)

^ag AUCKLAND CITY HOSPITAL   (New Zealand)

^ah WEILL CORNELL MEDICAL CENTER   (United States)

^ai UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^aj UNIVERSITY OF COLORADO   (United States)

^ak KAISER PERMANENTE   (United States)

^al FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^am CHILDREN S HOSPITAL OAKLAND   (United States)

^an UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ao UNIVERSITY OF TURIN   (Italy)

^ap VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aq UNIVERSITY OF VERONA   (Italy)

^ar CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^as STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^at MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^au NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 7; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS INSUFFICIENCY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0027517995     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199310283291804     Document Type: Article

References (37)

1. Boat TF, Welsh MJ, Beaudet AL. Cystic fibrosis. In: Scriver CL, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. Vol. 2. New York: McGraw-Hill, 1989:2649-80.
2. Rommens JM, Iannuzzi MC, Kerem B, Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065
3. Riordan JR, Rommens JM, Kerem B, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073 [Erratum, Science 1989;245:1437.]
4. Anderson MP, Rich DP, Gregory RJ, Smith AE, Welsh MJ Generation of cAMP-activated chloride currents by expression of CFTR. Science 1991; 251: 679-682
5. Kartner N, Hanrahan JW, Jensen TJ, Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 1991; 64: 681-691
6. Bear CE, Li CH, Kartner N, Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992; 68: 809-818
7. Kerem B, Rommens JM, Buchanan JA, Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080
8. Worldwide survey of the (delta)F508 mutation -- report from the cystic fibrosis genetic analysis consortium. Am J Hum Genet 1990; 47: 354-359
9. 508). N Engl J Med 1990; 323: 1517-1522
10. Santis G, Osborne L, Knight RA, Hodson ME Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990; 336: 1081-1084
11. Campbell PW III, Phillips JA III, Krishnamani MR, Maness KJ, Hazinski TA Cystic fibrosis: relationship between clinical status and F508 deletion. J Pediatr 1991; 118: 239-241
12. Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M Severity of cystic fibrosis in patients homozygous and heterozygous for δF508 mutation. Lancet 1991; 337: 631-634
13. Borgo G, Mastella G, Gasparini P, Zorzanello A, Doro R, Pignatti PF Pancreatic function and gene deletion F508 in cystic fibrosis. J Med Genet 1990; 27: 665-669
14. Hamosh A, Cutting GR. Genotype/phenotype relationships in cystic fibrosis. In: Dodge JD, Brock DJH, Widdicombe JW, eds. Current topics in cystic fibrosis. Vol. 1. New York: John Wiley, 1993:69-92.
15. Shoshani T, Augarten A, Gazit E, Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 1992; 50: 222-228
16. Osborne L, Santis G, Schwarz M, Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum Genet 1992; 89: 653-658
17. Hamosh A, King TM, Rosenstein BJ, Cystic fibrosis patients bearing both the common missense mutation Gly to Asp at codon 551 and the δF508 mutation are clinically indistinguishable from δF508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet 1992; 51: 245-250
18. Dork T, Wulbrand U, Richter T, Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. Hum Genet 1991; 87: 441-446
19. Liechti-Gallati S, Bonsall I, Malik N, Genotype/phenotype association in cystic fibrosis: analyses of the δF508, R553X, and 3905insT mutations. Pediatr Res 1992; 32: 175-178
20. Gasparini P, Borgo G, Mastella G, Bonizzato A, Dognini M, Pignatti PF Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease. J Med Genet 1992; 29: 558-562
21. Tsui L-C Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium. Hum Mutat 1992; 1: 197-203
22. Hamosh A, Trapnell BC, Zeitlin PL, Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest 1991; 88: 1880-1885
23. Jones CT, McIntosh I, Keston M, Ferguson A, Brock DJH Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum Mol Genet 1992; 1: 11-17
24. Hamosh A, Rosenstein BJ, Cutting GR CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. Hum Mol Genet 1992; 1: 542-544
25. Shwachman H, Kulczycki LL Long-term study of one hundred five patients with cystic fibrosis: studies made over a five- to fourteen-year period. Am J Dis Child 1958; 96: 6-15
26. Brasfield D, Hicks G, Soong S, Tiller RE The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63: 24-29
27. Chrispin AR, Norman AP The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 1974; 2: 101-106
28. SAS/STAT user's guide: release 6.03 ed. Cary, N.C.: SAS Institute, 1988.
29. Statistical Analysis and Epidemiology Research Corporation. EGRET: epidemiological graphics estimation and testing package. Seattle: Statistics and Epidemiology Research, 1990.
30. Kristidis P, Bozon D, Corey M, Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50: 1178-1184
31. Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982; 100: 857-862
32. Santis G, Osborne L, Knight R, Smith M, Davison T, Hodson M Genotype-phenotype relationship in cystic fibrosis: results from the study of monozygotic and dizygotic twins with cystic fibrosis. Pediatr Pulmonol 1992; 14: Suppl 8: 239-239 abstract.
33. Campbell PW III, Parker RA, Roberts BT, Krishnamani MR, Phillips JA III Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr 1992; 120: 261-264
34. 508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. Lancet 1990; 336: 512-512
35. Amos JA, Oates RD, Dean M, Congenital absence of the vas deferens: a primarily genital form of cystic fibrosis. Pediatr Pulmon 1992; 14: Suppl 8: 142-143
36. Carroll TP, McIntosh I, Egan ME, et al. Transmembrane mutations alter the channel characteristics of the cystic fibrosis transmembrane conductance regulator expressed in Xenopus oocytes. Cell Physiol Biochem (in press).
37. Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ Mutations in CFTR associated with mild-disease-form Cl-channels with altered pore properties. Nature 1993; 362: 160-164